tirzepatide 8/2 mg/ml 💊 — Mechanism of Action & Pharmacokinetics 👨‍⚕️ Mechanism of Action • Tirzepatide is the first dual GIP/GLP-1 receptor agonist. • Activates both: - Glucose-Dependent Insulinotropic Polypeptide (GIP) receptors Tirzepatide - Injectable Peptide

Pignatti C, Tantini B, Stefanelli C, Flamigni F

On the other hand, its pretty clear that once patients stop taking these GLP-1 drugs, the likelihood is that theyre going to regain weight as their metabolism normalizes and they start to consume more calories

Nauck MA, Meininger G, Sheng D, Terranella L, Stein PP

The unique aspect of this supplement lies in its ability to rejuvenate not just the gut but also various other body systems, including muscles, tendons, and blood vessels

Preclinical studies employing mouse models have demonstrated that nano-TQ effectively mitigates inflammation, erythema, scaling, epidermal thickness, and cytokine levels in psoriatic lesions